Subcutaneous abatacept for the treatment of rheumatoid arthritis-Reference-Cited by-同舟云学术

Subcutaneous abatacept for the treatment of rheumatoid arthritis

Published:2013-03-05 Issue:6 Volume:52 Page:986-997
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Schiff Michael

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/52/6/986/17388118/ket018.pdf

Reference38 articles.

1. The role of novel T cell costimulatory pathways in autoimmunity and transplantation;Yamada;J Am Soc Nephrol,2002

2. Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors;Westhovens;Ann Rheum Dis,2009

3. Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial;Kremer;Ann Intern Med,2006

4. Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial;Kremer;Ann Rheum Dis,2011

5. Remission according to different composite disease activity indices in biologic-naïve patients with rheumatoid arthritis treated with abatacept or infliximab plus methotrexate;Smolen;Arthritis Rheum,2011

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advances in rheumatoid arthritis;BMJ;2024-01-17

2. Costimulatory Blockade and Solid Organ Transplantation: The Past, Present, and Future;Kidney International Reports;2023-12

3. Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy;Frontiers in Immunology;2023-10-23

4. Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins;BioDrugs;2021-02-01

5. Two-year abatacept retention rate in clinical practice in the French ACTION cohort;Joint Bone Spine;2019-11